FIELD: biotechnology.
SUBSTANCE: invention represents an A/17/Singapore/2016/3571 (H3N2) influenza virus strain deposited in the State Collection of Viruses of the D.I.Ivanovsky Institute of Virology FGBU "N.F.Gamaleya Federal Research Center for Epidemiology & Microbiology" of Ministry of Health of Russia, No. 2861.
EFFECT: invention can be used for production of live influenza intranasal influenza vaccine for adults and children.
1 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
VACCINE STRAIN OF INFLUENZA VIRUS A/17/SWITZERLAND/2017/51 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2715674C1 |
VACCINE STRAIN OF INFLUENZA A/17/KANSAS/2017/631 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2732610C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2017/7178 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2711101C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/3610 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2734897C1 |
VACCINE INFLUENZA VIRUS STRAIN A/17/HONGKONG/2014/8296 (H3N2) FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2016 |
|
RU2606019C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA VIRUS A/17/TASMANIA/2020/151 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2023 |
|
RU2825672C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/MICHIGAN/2020/484 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825583C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/HONG KONG/2019/2573 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783894C1 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/NEWCASTLE/2018/22 (H3N2) FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783887C1 |
Authors
Dates
2019-03-28—Published
2018-05-29—Filed